NDC 71384-630

MKO Melt

Midazolaam - Ketamine Hcl - Ondansetron

MKO Melt is a Sublingual Troche in the Human Prescription Drug category. It is labeled and distributed by Imprimis Njof, Llc. The primary component is Midazolam; Ketamine Hydrochloride; Ondansetron Hydrochloride.

Product ID71384-630_7cdebcbc-03dc-1669-e053-2991aa0a3cd6
NDC71384-630
Product TypeHuman Prescription Drug
Proprietary NameMKO Melt
Generic NameMidazolaam - Ketamine Hcl - Ondansetron
Dosage FormTroche
Route of AdministrationSUBLINGUAL
Marketing Start Date2018-12-01
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameImprimis NJOF, LLC
Substance NameMIDAZOLAM; KETAMINE HYDROCHLORIDE; ONDANSETRON HYDROCHLORIDE
Active Ingredient Strength3 mg/1; mg/1; mg/1
Pharm ClassesBenzodiazepine [EPC],Benzodiazepines [CS],General Anesthesia [PE],General Anesthetic [EPC],Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC]
DEA ScheduleCIII
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 71384-630-21

21 TROCHE in 1 BLISTER PACK (71384-630-21)
Marketing Start Date2018-12-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 71384-630-21 [71384063021]

MKO Melt TROCHE
Marketing Categoryunapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-12-01
Marketing End Date2019-03-04
Inactivation Date2020-01-31
Reactivation Date2020-02-10

Drug Details

Active Ingredients

IngredientStrength
MIDAZOLAM3 mg/1

OpenFDA Data

SPL SET ID:7cdebcbc-03db-1669-e053-2991aa0a3cd6
Manufacturer
UNII

Pharmacological Class

  • Benzodiazepine [EPC]
  • Benzodiazepines [CS]
  • General Anesthesia [PE]
  • General Anesthetic [EPC]
  • Serotonin 3 Receptor Antagonists [MoA]
  • Serotonin-3 Receptor Antagonist [EPC]

Trademark Results [MKO Melt]

Mark Image

Registration | Serial
Company
Trademark
Application Date
MKO MELT
MKO MELT
97786334 not registered Live/Pending
Melt Pharmaceuticals, Inc.
2023-02-08
MKO MELT
MKO MELT
86966404 5158235 Live/Registered
MELT PHARMACEUTICALS, INC.
2016-04-06

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.